According to the National Institutes of Health (NIH), no Tolerable Upper Intake Level (UL) has been established for B12, indicating that the risk of harm from high doses is low [*]
Semaglutide: Ozempic, Wegovy, and compounded formulations Semaglutide is the most widely prescribed GLP-1 receptor agonist, available in both brand-name and compounded forms
Metabolic unpredictability: Simultaneously altering multiple metabolic pathways incretin signalling, glucagon activity, and NAD+ metabolism without clinical oversight introduces unpredictable physiological consequences
These include pain, swelling, itching, bruising, and redness
This is why combining clinical trial data with user experience reports provides a more complete picture